Original Article
Neuropsychopharmacology (2006) 31, 2748–2757. doi:10.1038/sj.npp.1301197; published online 23 August 2006
Clinical Research
An Experimental Study of Catechol-O-Methyltransferase Val158Met Moderation of
-9-Tetrahydrocannabinol-Induced Effects on Psychosis and Cognition
Cécile Henquet1,5, Araceli Rosa2,5, Lydia Krabbendam1, Sergi Papiol2, Lourdes Fa
anás2, Marjan Drukker1, Johannes G Ramaekers3 and Jim van Os1,4
- 1Department of Psychiatry and Neuropsychology, South Limburg Mental Health Research and Teaching Network, EURON, Maastricht University, Maastricht, The Netherlands
- 2Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain
- 3Experimental Psychopharmacology Unit, Maastricht University, Maastricht, The Netherlands
- 4Division of Psychological Medicine, Institute of Psychiatry, London, UK
Correspondence: Dr J van Os, Department of Psychiatry and Neuropsychology, Maastricht University, PO BOX 616 (DRT 10), 6200 MD Maastricht, The NetherlandsM. Tel: +31 43 3875443; Fax: +31 43 3875444; E-mail: j.vanos@sp.unimaas.nl
5These two authors contributed equally to this work.
Received 24 March 2006; Revised 19 July 2006; Accepted 20 July 2006; Published online 23 August 2006.
Abstract
Observational studies have suggested that psychometric psychosis liability and a functional polymorphism in the catechol-O-methyltransferase (COMT Val158Met) gene moderate the psychosis-inducing effect of cannabis. To replicate and extend this finding, a double-blind, placebo-controlled cross-over design was used in which patients with a psychotic disorder (n=30), relatives of patients with a psychotic disorder (n=12), and healthy controls (n=32) were exposed to
-9-tetrahydrocannabinol (
-9-THC, the principal component of cannabis) or placebo, followed by cognitive assessment and assessment of current psychotic experiences. Previous expression of psychometric psychosis liability was also assessed. Models of current psychotic experiences and cognition were examined with multilevel random regression analyses to assess (i) main effects of genotype and condition, (ii) interactions between condition and genotype, and (iii) three-way interactions between condition, genotype, and psychometric psychosis liability. Carriers of the Val allele were most sensitive to
-9-THC-induced psychotic experiences, but this was conditional on prior evidence of psychometric psychosis liability.
-9-THC impacted negatively on cognitive measures. Carriers of the Val allele were also more sensitive to
-9-THC-induced memory and attention impairments compared to carriers of the Met allele. Experimental effects of
-9-THC on cognition and psychosis are moderated by COMT Val158Met genotype, but the effects may in part be conditional on the additional presence of pre-existing psychosis liability. The association between cannabis and psychosis may represent higher order gene–environment and gene–gene interactions.
Keywords:
delta-9-tetrahydrocannabinol, genetic polymorphism, dopamine, schizophrenia, neuropsychology, genetic predisposition
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
Neuropsychopharmacology Original Article
Cannabinoids Influence Lipid?Arachidonic Acid Pathways in Schizophrenia
Neuropsychopharmacology Original Article
Neuropsychopharmacology Original Article

